Oncolytics Biotech Statistics
Total Valuation
ONCY has a market cap or net worth of $81.45 million. The enterprise value is $46.96 million.
| Market Cap | 81.45M |
| Enterprise Value | 46.96M |
Important Dates
The next estimated earnings date is Tuesday, May 7, 2024, before market open.
| Earnings Date | May 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ONCY has 75.42 million shares outstanding.
| Shares Outstanding | 75.42M |
| Owned by Insiders (%) | 3.90% |
| Owned by Institutions (%) | 6.78% |
| Float | 66.96M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.96 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.01, with a Debt / Equity ratio of 0.02.
| Current Ratio | 9.01 |
| Quick Ratio | 8.24 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -106.20% and return on invested capital (ROIC) is -120.74%.
| Return on Equity (ROE) | -106.20% |
| Return on Assets (ROA) | -72.90% |
| Return on Capital (ROIC) | -120.74% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$956,966 |
| Employee Count | 29 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ONCY has paid $97,000 in taxes.
| Income Tax | 97,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -4.42% in the last 52 weeks. The beta is 1.46, so ONCY's price volatility has been higher than the market average.
| Beta (1Y) | 1.46 |
| 52-Week Price Change | -4.42% |
| 50-Day Moving Average | 1.06 |
| 200-Day Moving Average | 1.61 |
| Relative Strength Index (RSI) | 50.78 |
| Average Volume (30 Days) | 369,085 |
Short Selling Information
| Short Interest | 928,074 |
| Short Previous Month | 930,654 |
| Short % of Shares Out | 1.31% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 3.41 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -33.79M |
| Pretax Income | -27.66M |
| Net Income | -27.75M |
| EBITDA | -27.25M |
| EBIT | -27.66M |
| Earnings Per Share (EPS) | -$0.41 |
Balance Sheet
The company has $34.91 million in cash and $423,000 in debt, giving a net cash position of $34.49 million or $0.46 per share.
| Cash & Cash Equivalents | 34.91M |
| Total Debt | 423,000 |
| Net Cash | 34.49M |
| Net Cash Per Share | $0.46 |
| Equity / Book Value | 27.56M |
| Book Value Per Share | 0.37 |
| Working Capital | 33.94M |
Cash Flow
In the last 12 months, operating cash flow was -$28.45 million and capital expenditures -$8,000, giving a free cash flow of -$28.46 million.
| Operating Cash Flow | -28.45M |
| Capital Expenditures | -8,000 |
| Free Cash Flow | -28.46M |
| FCF Per Share | -$0.42 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ONCY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -16.53% |
| Shareholder Yield | -16.53% |
| Earnings Yield | -34.07% |
| FCF Yield | -34.94% |
Analyst Forecast
The average price target for ONCY is $5.50, which is 409.26% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $5.50 |
| Price Target Difference | 409.26% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on May 25, 2018. It was a reverse split with a ratio of 10:95.
| Last Split Date | May 25, 2018 |
| Split Type | Reverse |
| Split Ratio | 10:95 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |